GMP Bio
Tracked across 3 events · 35 articles · First seen Apr 06, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: GMP Bio is a joint venture in which Oncotelic Therapeutics Inc. owns 45%, advancing its own pipeline of drug candidates that complement Oncotelic Therapeutics Inc.'s strategic position.
Apr 06, 2026 · 23 articles
ERGEN INTELLIGENCE
Track GMP Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard